Japan Network Point-of-care Glucose Testing Market Size & Outlook
Related Markets
Japan network point-of-care glucose testing market highlights
- The Japan network point-of-care glucose testing market generated a revenue of USD 79.0 million in 2023 and is expected to reach USD 105.2 million by 2030.
- The Japan market is expected to grow at a CAGR of 4.1% from 2024 to 2030.
- In terms of segment, accu-chek inform ii was the largest revenue generating product in 2023.
- CareSens Expert Plus is the most lucrative product segment registering the fastest growth during the forecast period.
Network point-of-care glucose testing market data book summary
| Market revenue in 2023 | USD 79.0 million |
| Market revenue in 2030 | USD 105.2 million |
| Growth rate | 4.1% (CAGR from 2024 to 2030) |
| Largest segment | Accu-chek inform ii |
| Fastest growing segment | CareSens Expert Plus |
| Historical data | 2018 - 2022 |
| Base year | 2023 |
| Forecast period | 2024 - 2030 |
| Quantitative units | Revenue in USD million |
| Market segmentation | I-STAT, CareSens Expert Plus, Accu-Chek Inform II, StatStrip, HemoCue |
| Key market players worldwide | Roche Holding AG ADR, Abbott Laboratories, Nova Biomedical, Bayer AG, Danaher Corp |
Other key industry trends
- In terms of revenue, Japan accounted for 5.9% of the global network point-of-care glucose testing market in 2023.
- Country-wise, U.S. is expected to lead the global market in terms of revenue in 2030.
- In Asia Pacific, Japan network point-of-care glucose testing market is projected to lead the regional market in terms of revenue in 2030.
- China is the fastest growing regional market in Asia Pacific and is projected to reach USD 90.8 million by 2030.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Network Point-of-Care Glucose Testing Market Scope
Network Point-of-Care Glucose Testing Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|---|---|---|---|
| Bayer AG | View profile | 99723 | Kaiser-Wilhelm-Allee 1, Leverkusen, NW, Germany, 51368 | https://www.bayer.com |
| Nova Biomedical | View profile | 501-1000 | Waltham, Massachusetts, United States, North America | http://www.novabio.us |
| Danaher Corp | View profile | 63000 | 2200 Pennsylvania Avenue, N.W., Suite 800W, Washington, DC, United States, 20037-1701 | https://www.danaher.com |
| Abbott Laboratories | View profile | 114000 | 100 Abbott Park Road, Abbott Park, IL, United States, 60064-6400 | https://www.abbottinvestor.com |
| Roche Holding AG ADR | View profile | 103605 | Grenzacherstrasse 124, Basel, Switzerland, 4070 | https://www.roche.com |
Japan network point-of-care glucose testing market outlook
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to network point-of-care glucose testing market will help companies and investors design strategic landscapes.
Accu-chek inform ii was the largest segment with a revenue share of 51.65% in 2023. Horizon Databook has segmented the Japan network point-of-care glucose testing market based on i-stat, caresens expert plus, accu-chek inform ii, statstrip, hemocue covering the revenue growth of each sub-segment from 2018 to 2030.
Japan is reported to have the largest geriatric population in the world, which can be attributed to increased life expectancy due to medical advancements and reduced fertility rate as a result of post– world war effects.
Moreover, geriatric population is expected to increase in the coming years. According to demographic estimates, about 25% of Japanese population is 65 years and above, which is estimated to rise up to 40% of the country’s population by 2060. Increasing geriatric population is expected to contribute significantly to rising diabetes burden in the country.
In 2019, the number of people suffering from diabetes in Japan reached 9.3 million with aging and obesity being the key causative factors. Such high incidence of diabetes in the country has led to an increase in the need for improving access to established glucose meter brands and ensuring their adoption.
Reasons to subscribe to Japan network point-of-care glucose testing market databook:
-
Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
-
Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
-
Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
-
Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
-
Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of Japan network point-of-care glucose testing market databook
-
Our clientele includes a mix of network point-of-care glucose testing market companies, investment firms, advisory firms & academic institutions.
-
30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
-
Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
-
The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of country-level data and insights on the Japan network point-of-care glucose testing market , including forecasts for subscribers. This country databook contains high-level insights into Japan network point-of-care glucose testing market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Partial client list
Japan network point-of-care glucose testing market size, by product, 2018-2030 (US$M)
Japan Network Point-of-Care Glucose Testing Market Outlook Share, 2023 & 2030 (US$M)
Related industry reports
Related statistics
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
